Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis

被引：0
|
作者：
Clélia Monchablon
Henri Gondé
Sophie Pouplin
Rémi Varin
Olivier Vittecoq
Thierry Lequerré
机构：
[1] Rouen University Hospital,Department of Pharmacy
[2] Rouen University Hospital,Normandie Univ, UNIROUEN, U1234 Inserm, Department of Pharmacy
[3] Rouen University Hospital,Department of Rheumatology
[4] Rouen University Hospital,Normandie Univ, UNIROUEN, U1234 Inserm, Department of Rheumatology
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Adherence; Medication; Questionnaire; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：207 / 216
页数：9
相关论文
共 50 条
  • [41] Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
    Ahmad Y. Abuhelwa
    Ashley M. Hopkins
    Michael J. Sorich
    Susanna Proudman
    David J. R. Foster
    Michael D. Wiese
    Scientific Reports, 10
  • [42] Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis
    Roy Fleischmann
    Clinical Rheumatology, 2021, 40 : 4369 - 4372
  • [43] Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis
    Hodkinson, B.
    Musenge, E.
    Ally, M.
    Meyer, P. W. A.
    Anderson, R.
    Tikly, M.
    CLINICAL RHEUMATOLOGY, 2012, 31 (04) : 613 - 619
  • [44] Prescribing patterns and clinical outcomes of biological disease-modifying anti-rheumatic drugs for rheumatoid arthritis in Spain
    Martinez-Mugica, C.
    Manso, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (15) : 8177 - 8184
  • [45] Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
    Abuhelwa, Ahmad Y.
    Hopkins, Ashley M.
    Sorich, Michael J.
    Proudman, Susanna
    Foster, David J. R.
    Wiese, Michael D.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [46] Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs
    Arias de la Rosa, Ivan
    Escudero-Contreras, Alejandro
    Ruiz-Ponce, Miriam
    Roman-Rodriguez, Cristobal
    Perez-Sanchez, Carlos
    Abalos-Aguilera, Maria del Carmen
    Ortega-Castro, Rafaela
    Alcaide, Juan
    Murri, Mora
    Font, Pilar
    Calvo-Gutierrez, Jerusalem
    Luque-Tevar, Maria
    Patino-Trives, Alejandra Maria
    Guzman-Ruiz, Rocio
    Malagon, Maria del Mar
    Tinahones, Francisco Jose
    Collantes-Estevez, Eduardo
    Lopez-Pedrera, Chary
    Barbarroja, Nuria
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [47] Adverse drug reactions associated with the use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Enrique Machado-Alba, Jorge
    Felipe Ruiz, Andres
    Enrique Machado-Duque, Manuel
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (06): : 396 - 401
  • [48] Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
    Yen, J. -H.
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (10) : 688 - 692
  • [49] Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis
    Rodriguez-Rodriguez, L.
    Jover-Jover, J. A.
    Fontsere, O.
    Pena-Blanco, R. C.
    Leon, L.
    Fernandez-Gutierrez, B.
    Abasolo, L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (06) : 433 - 436
  • [50] Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
    Akter, Ripa
    Maksymowych, Walter P.
    Martin, M. Liam
    Hogan, David B.
    CANADIAN GERIATRICS JOURNAL, 2020, 23 (02) : 184 - 189
12345